AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+4.82%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.16B
AUM Growth
+$1.16B
(+7.2%)
Cap. Flow
+$51.2M
Cap. Flow
% of AUM
4.42%
Top 10 Holdings %
Top 10 Hldgs %
38.88%
Holding
90
New
27
Increased
21
Reduced
13
Closed
22
Top Buys
| 1 |
Edgewell Personal Care
EPC
|
$55.1M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$44.8M |
| 3 |
J.M. Smucker
SJM
|
$34.8M |
| 4 |
Incyte
INCY
|
$28.7M |
| 5 |
Theravance Biopharma
TBPH
|
$26.8M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$43.6M |
| 2 |
Freshpet
FRPT
|
$39.7M |
| 3 |
Cheesecake Factory
CAKE
|
$33.8M |
| 4 |
Post Holdings
POST
|
$29.7M |
| 5 |
Assertio
ASRT
|
$28M |
Sector Composition
| 1 | Healthcare | 49.93% |
| 2 | Consumer Discretionary | 30.9% |
| 3 | Consumer Staples | 11.38% |
| 4 | Communication Services | 0.98% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $71.2M | 4.65% | 16,414,400 +364,400 | +2% | +$1.58M |
|
|
2
Edgewell Personal Care
EPC
$1.12B
| $55.1M | 3.6% | +1,092,000 | New | +$55.1M |
|
|
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $44.8M | 2.92% | +2,400,000 | New | +$44.8M |
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $44.2M | 2.88% | 128,000 +20,000 | +19% | +$6.9M |
|
5
Vanda Pharmaceuticals
VNDA
$279M
| $42.4M | 2.77% | 2,224,000 -376,000 | -14% | -$7.16M |
|
6
Harley-Davidson
HOG
$3.54B
| $42.1M | 2.75% | 1,000,000 +272,000 | +37% | +$11.4M |
|
|
SGI
7
Somnigroup International Inc.
SGI
$17.6B
| $41.1M | 2.69% | 856,000 +176,000 | +26% | +$8.46M |
|
|
AMAG
8
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $40.6M | 2.65% | 2,080,000 +176,000 | +9% | +$3.43M |
|
|
9
J.M. Smucker
SJM
$11.8B
| $34.8M | 2.27% | +324,000 | New | +$34.8M |
|
10
United Parks & Resorts
PRKS
$2.89B
| $34.4M | 2.25% | 1,576,000 -424,000 | -21% | -$9.25M |
|
|
DESP
11
DELISTED
Despegar.com
DESP
| $33.4M | 2.18% | 1,592,000 +984,000 | +162% | +$20.6M |
|
12
CVS Health
CVS
$92.8B
| $32.2M | 2.1% | 500,000 +8,000 | +2% | +$515K |
|
|
PLYA
13
DELISTED
Playa Hotels & Resorts
PLYA
| $31.7M | 2.07% | 2,936,000 | – | – |
|
|
ATRS
14
DELISTED
Antares Pharma, Inc.
ATRS
| $31.1M | 2.03% | 12,050,000 -510,000 | -4% | -$1.32M |
|
|
15
Incyte
INCY
$16.5B
| $28.7M | 1.87% | +428,000 | New | +$28.7M |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $28.4M | 1.85% | 624,000 +156,000 | +33% | +$7.09M |
|
|
BLUE
17
DELISTED
bluebird bio
BLUE
| $28.3M | 1.84% | 180,000 +120,000 | +200% | +$18.8M |
|
18
Hanesbrands
HBI
$2.23B
| $28.2M | 1.84% | 1,280,000 -720,000 | -36% | -$15.9M |
|
|
GAP
19
The Gap, Inc.
GAP
$8.21B
| $27.9M | 1.82% | 860,000 +220,000 | +34% | +$7.13M |
|
20
Capri Holdings
CPRI
$2.45B
| $27.8M | 1.82% | 418,000 +118,000 | +39% | +$7.86M |
|
|
21
Theravance Biopharma
TBPH
$699M
| $26.8M | 1.75% | +1,180,000 | New | +$26.8M |
|
22
Simply Good Foods
SMPL
$2.88B
| $21.1M | 1.38% | +1,460,000 | New | +$21.1M |
|
23
B&G Foods
BGS
$361M
| $20.9M | 1.37% | +700,000 | New | +$20.9M |
|
|
PGNX
24
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $20.4M | 1.33% | 2,536,000 +136,000 | +6% | +$1.09M |
|
25
Light & Wonder
LNW
$7.76B
| $18.1M | 1.18% | +368,000 | New | +$18.1M |
|